These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24928215)
1. A Galleria mellonella infection model reveals double and triple antibiotic combination therapies with enhanced efficacy versus a multidrug-resistant strain of Pseudomonas aeruginosa. Krezdorn J; Adams S; Coote PJ J Med Microbiol; 2014 Jul; 63(Pt 7):945-955. PubMed ID: 24928215 [TBL] [Abstract][Full Text] [Related]
2. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model. Adamson DH; Krikstopaityte V; Coote PJ J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513 [TBL] [Abstract][Full Text] [Related]
3. Steroidal alkaloids and conessine from the medicinal plant Holarrhena antidysenterica restore antibiotic efficacy in a Galleria mellonella model of multidrug-resistant Pseudomonas aeruginosa infection. Siriyong T; Voravuthikunchai SP; Coote PJ BMC Complement Altern Med; 2018 Oct; 18(1):285. PubMed ID: 30340578 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection. Hill L; Veli N; Coote PJ Int J Antimicrob Agents; 2014 Mar; 43(3):254-61. PubMed ID: 24361354 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella. Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845 [TBL] [Abstract][Full Text] [Related]
6. Demonstration of the efficacy of curcumin on carbapenem-resistant Pseudomonas aeruginosa with Galleria mellonella larvae model. Ozturk S Arch Microbiol; 2022 Jul; 204(8):524. PubMed ID: 35882691 [TBL] [Abstract][Full Text] [Related]
7. Two Novel Bacteriophages Improve Survival in Jeon J; Yong D Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445 [TBL] [Abstract][Full Text] [Related]
8. Dual β-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition. Siriyong T; Murray RM; Bidgood LE; Young SA; Wright F; Parcell BJ; Voravuthikunchai SP; Coote PJ Sci Rep; 2019 Jun; 9(1):9098. PubMed ID: 31235728 [TBL] [Abstract][Full Text] [Related]
9. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of Betts JW; Hornsey M; Higgins PG; Lucassen K; Wille J; Salguero FJ; Seifert H; La Ragione RM J Med Microbiol; 2019 Oct; 68(10):1552-1559. PubMed ID: 31419210 [No Abstract] [Full Text] [Related]
10. Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones. Montero MM; Domene Ochoa S; López-Causapé C; VanScoy B; Luque S; Sorlí L; Campillo N; Padilla E; Prim N; Segura C; Pomar V; Rivera A; Grau S; Ambrose PG; Oliver A; Horcajada JP J Glob Antimicrob Resist; 2019 Sep; 18():37-44. PubMed ID: 31154007 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model. Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497 [TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates. Nazli E; Zer Y; Eksi F J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417 [TBL] [Abstract][Full Text] [Related]
13. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa. Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains. Erdem I; Kucukercan M; Ceran N Chemotherapy; 2003 Dec; 49(6):294-7. PubMed ID: 14671429 [TBL] [Abstract][Full Text] [Related]
15. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
16. Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model. Wei W; Yang H; Hu L; Ye Y; Li J J Microbiol Immunol Infect; 2017 Dec; 50(6):821-830. PubMed ID: 26725481 [TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection. Wang Y; Li C; Wang J; Bai N; Zhang H; Chi Y; Cai Y Microbiol Spectr; 2022 Oct; 10(5):e0146822. PubMed ID: 36102678 [TBL] [Abstract][Full Text] [Related]